Grace Therapeutics (GRCE) Q4 2024 Earnings

Nov 13Confirmed
Q3 2024
Q4 2024
-0.37
-0.33
-0.28
-0.24

Details

Expected EPS
-0.37
Actual EPS
-0.3
Surprise EPS
0.07
Surprise Percent
+18.92%

Description

⁨Grace Therapeutics⁩ (⁦GRCE⁩) has reported earnings of ⁦-0.3⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts